Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grünberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R.
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.
Wien Klin Wochenschr. 2022; 134(19-20):683-692
Doi: 10.1007/s00508-022-02082-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Balic Marija
- Rinnerthaler Gabriel
- Co-Autor*innen der Med Uni Graz
- Krippl Peter
- Petru Edgar
- Suppan Christoph
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In the past 12 months a plethora of relevant novel data for the treatment of metastatic HER2 positive breast cancer were published. To bring this new evidence into a clinical perspective, a group of Austrian breast cancer specialists updated their previously published treatment algorithm for those patients. For this consensus paper a total of eight scenarios were developed in which treatment strategies appropriate for specific patient profiles were evaluated. Consensus was established by detailed discussions of each scenario and by reaching full consensus.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Female - administration & dosage
- Breast Neoplasms - drug therapy, pathology
- Receptor, ErbB-2 - therapeutic use
- Austria - administration & dosage
- Neoplasms, Second Primary - administration & dosage
- Algorithms - administration & dosage
- Find related publications in this database (Keywords)
- Advanced breast cancer
- Erbb2
- Systemic therapy
- Antibody-drug conjugates
- Tyrosin kinase inhibitors